everding-CROPJohn Everding served two tours of duty in the Vietnam War during 1968-1969 with the U.S. Army and was honorably decorated for heroic service to his country. During his tours of duty in Vietnam he received multiple awards – eleven in total – for heroism both in ground combat and air service.

Mr. Everding is also a highly regarded professional horseman with numerous awards to his name.

He has been very successful in his thirty plus years of business life and his excellent consulting skills have been both welcomed and honored internationally in China, South America and Europe. The application of his widely proven business skills have led to success for several start-up firms and also existing companies.

His business expertise includes financial management, business development, and joint ventures. His professional business associations, combined with his passion for helping people and celebrating life, is clearly demonstrated by the creation of Luminec Corporation and the Luminec Group of Companies which have drawn an extraordinary group of people as members of the Board of Directors of Luminec Corporation.

John Everding, co-founder of Luminec Corporation and Steven R. Schutt, its founder, together have created Tri-AminoTM and TAFA400TM, two revolutionary patent-pending formulations invented by Steven Schutt for exclusive use by the Luminec Group of Companies. These two formulas are comprised of water-soluble blends of amino acids that embody All-Natural based healing agents that can be delivered through oral, inhalant, topical, and both arterial and venous administration. Amnion Animal Sciences Corporation is the first of the Luminec Group of Companies licensed to utilize these unique formulations.

TAFA400TM benefits from the blending of Carbohydrate Derived Fulvic Acid in a chemically pure pharmaceutical grade with the Tri-AminoTM molecule, producing the most effective non-toxic, all-natural, broad-spectrum, anti-fungal, anti-bacterial, anti-microbial, and anti-viral agent known to man. The treatments derived from these patent-pending molecules have demonstrated properties that rapidly clean and heal broad-spectrum topical wounds, including all degrees of burns, topical lesions and ulcers, fungi, and spores, providing instant relief from pain, itching, bleeding, burning and inflammation for both animals and humans.

“In addition to offering transformational healing products throughout the developed world, it is our goal to provide underprivileged individuals in third world countries with a unique stand-alone formula in the form of a broad-spectrum topical lotion for the treatment of diseases and most skin injuries (including burns). With full regard for basic human rights, it is our intent to deliver this product in a cost-effective manner never seen before.”

—John & Steven